Qlife Holding AB (publ) (QLIFE.ST)

SEK 2.1

(5.53%)

Market Cap (In SEK)

14.82 Million

Revenue (In SEK)

244 Thousand

Net Income (In SEK)

-159.95 Million

Avg. Volume

88.26 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.301-49.2
PE
-
EPS
-
Beta Value
0.853
ISIN
SE0013486552
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Thomas Warthoe
Employee Count
-
Website
https://www.qlifeholding.com
Ipo Date
2020-03-02
Details
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.